BioNTech And Pfizer To Seek Emergency Authorization For Covid-19 Vaccination
Video Credit: Wochit News - Duration: 00:32s - Published
BioNTech And Pfizer To Seek Emergency Authorization For Covid-19 Vaccination
BioNTech and its partner, Pfizer, will seek emergency approval for their Covid-19 vaccine candidate.
The drug companies will file paperwork for the emergency use of the vaccine with the US Food and Drug Administration (FDA).
In a final analysis of the Phase 3 trial, the vaccine was found to be 95% effective in preventing Covid-19.
The vaccine has been shown to work in all age populations.
According to CNN, the new vaccine has shown no serious safety concerns.
![Moderna seeks U.S., EU vaccine authorization [Video]](https://video.newsserve.net/300/v/20201130/2011301838-Moderna-seeks-EU-vaccine-authorization.jpg)
![Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval [Video]](https://video.newsserve.net/300/v/20201130/1313844230-Moderna-to-Submit-COVID-19-Vaccine-for-FDA.jpg)
![Moderna to Ask FDA for Emergency Clearance for Its COVID-19 Vaccine [Video]](https://video.newsserve.net/300/v/20201130/2011301331-Moderna-to-Ask-FDA-for-Emergency-Clearance-for.jpg)
